Login / Signup

Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.

Marc HafnerMario NiepelPeter K Sorger
Published in: Nature biotechnology (2018)
Keyphrases
  • papillary thyroid
  • adverse drug
  • squamous cell
  • cell therapy
  • squamous cell carcinoma
  • emergency department
  • lymph node metastasis
  • stem cells
  • drug induced
  • mesenchymal stem cells